Annual Retained Earnings
-$381.55 M
+$8.31 M+2.13%
December 31, 2023
Summary
- As of February 8, 2025, PLX annual retained earnings is -$381.55 million, with the most recent change of +$8.31 million (+2.13%) on December 31, 2023.
- During the last 3 years, PLX annual retained earnings has fallen by -$34.20 million (-9.85%).
Performance
PLX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$384.89 M
+$3.24 M+0.83%
September 30, 2024
Summary
- As of February 8, 2025, PLX quarterly retained earnings is -$384.89 million, with the most recent change of +$3.24 million (+0.83%) on September 30, 2024.
- Over the past year, PLX quarterly retained earnings has dropped by -$9.38 million (-2.50%).
- PLX quarterly retained earnings is now -17185.86% below its all-time high of -$2.23 million, reached on March 31, 1999.
Performance
PLX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
PLX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.1% | -2.5% |
| 3 y3 years | -9.8% | -2.5% |
| 5 y5 years | -18.3% | -2.5% |
PLX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1.8% | +2.1% | -2.6% | +2.1% |
| 5 y | 5-year | -11.9% | +2.1% | -13.5% | +2.1% |
| alltime | all time | <-9999.0% | +2.1% | <-9999.0% | +2.1% |
Protalix BioTherapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$384.89 M(-0.8%) |
| Jun 2024 | - | -$388.12 M(+0.6%) |
| Mar 2024 | - | -$385.92 M(+1.1%) |
| Dec 2023 | -$381.55 M(-2.1%) | -$381.55 M(+1.6%) |
| Sep 2023 | - | -$375.50 M(-4.4%) |
| Mar 2023 | - | -$392.99 M(+0.8%) |
| Dec 2022 | -$389.86 M(+4.0%) | -$389.86 M(+1.0%) |
| Sep 2022 | - | -$386.12 M(+0.9%) |
| Jun 2022 | - | -$382.55 M(+1.4%) |
| Mar 2022 | - | -$377.22 M(+0.6%) |
| Dec 2021 | -$374.93 M(+7.9%) | -$374.93 M(+7.9%) |
| Dec 2020 | -$347.35 M(+1.9%) | -$347.35 M(+2.4%) |
| Mar 2020 | - | -$339.16 M(-0.5%) |
| Dec 2019 | -$340.83 M(+5.7%) | -$340.83 M(+3.3%) |
| Mar 2019 | - | -$329.82 M(+2.3%) |
| Dec 2018 | -$322.55 M(+8.9%) | -$322.55 M(-3.5%) |
| Sep 2018 | - | -$334.17 M(+4.9%) |
| Jun 2018 | - | -$318.63 M(+7.6%) |
| Dec 2017 | -$296.10 M(+39.2%) | -$296.10 M(+4.7%) |
| Sep 2017 | - | -$282.79 M(+4.2%) |
| Jun 2017 | - | -$271.35 M(+27.6%) |
| Dec 2016 | -$212.66 M(+16.0%) | -$212.66 M(+10.8%) |
| Mar 2016 | - | -$191.89 M(+4.7%) |
| Dec 2015 | -$183.29 M(-24.0%) | -$183.29 M(-28.5%) |
| Sep 2015 | - | -$256.19 M(+1.5%) |
| Jun 2015 | - | -$252.37 M(+2.1%) |
| Mar 2015 | - | -$247.30 M(+2.5%) |
| Dec 2014 | -$241.33 M(+14.2%) | -$241.33 M(+3.6%) |
| Sep 2014 | - | -$232.86 M(+3.6%) |
| Jun 2014 | - | -$224.85 M(+2.8%) |
| Mar 2014 | - | -$218.73 M(+3.5%) |
| Dec 2013 | -$211.38 M(+15.1%) | -$211.38 M(+5.4%) |
| Sep 2013 | - | -$200.50 M(+3.0%) |
| Jun 2013 | - | -$194.75 M(+3.6%) |
| Mar 2013 | - | -$187.92 M(+2.4%) |
| Dec 2012 | -$183.59 M(+6.8%) | -$183.59 M(+5.7%) |
| Sep 2012 | - | -$173.72 M(+3.3%) |
| Jun 2012 | - | -$168.24 M(-5.4%) |
| Mar 2012 | - | -$177.88 M(+3.4%) |
| Dec 2011 | -$171.98 M(+27.0%) | -$171.98 M(+5.5%) |
| Sep 2011 | - | -$163.06 M(+5.8%) |
| Jun 2011 | - | -$154.19 M(+9.7%) |
| Mar 2011 | - | -$140.50 M(+3.7%) |
| Dec 2010 | -$135.45 M | -$135.45 M(+6.7%) |
| Sep 2010 | - | -$126.92 M(+2.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2010 | - | -$124.45 M(+8.8%) |
| Mar 2010 | - | -$114.41 M(+7.5%) |
| Dec 2009 | -$106.45 M(+41.9%) | -$106.45 M(+41.9%) |
| Dec 2008 | -$75.01 M(+74.5%) | -$75.01 M(+27.5%) |
| Sep 2008 | - | -$58.83 M(+12.4%) |
| Jun 2008 | - | -$52.34 M(+8.8%) |
| Mar 2008 | - | -$48.11 M(+11.9%) |
| Dec 2007 | -$42.99 M(+109.6%) | -$42.99 M(+13.6%) |
| Sep 2007 | - | -$37.86 M(+14.3%) |
| Jun 2007 | - | -$33.12 M(+38.2%) |
| Mar 2007 | - | -$23.96 M(+16.8%) |
| Dec 2006 | -$20.51 M(+84.4%) | -$20.51 M(+425.7%) |
| Sep 2006 | - | -$3.90 M(+2.8%) |
| Jun 2006 | - | -$3.79 M(-0.8%) |
| Mar 2006 | - | -$3.82 M(-65.6%) |
| Dec 2005 | -$11.12 M(+197.5%) | -$11.12 M(+193.2%) |
| Sep 2005 | - | -$3.79 M(+0.8%) |
| Jun 2005 | - | -$3.76 M(+0.3%) |
| Mar 2005 | - | -$3.75 M(+0.3%) |
| Dec 2004 | -$3.74 M(+4.5%) | -$3.74 M(+0.9%) |
| Sep 2004 | - | -$3.71 M(+1.2%) |
| Jun 2004 | - | -$3.66 M(+1.6%) |
| Mar 2004 | - | -$3.60 M(+0.7%) |
| Dec 2003 | -$3.58 M(+4.1%) | -$3.58 M(+1.3%) |
| Sep 2003 | - | -$3.53 M(+0.9%) |
| Jun 2003 | - | -$3.50 M(+0.9%) |
| Mar 2003 | - | -$3.47 M(+0.9%) |
| Dec 2002 | -$3.44 M(+4.6%) | -$3.44 M(+1.5%) |
| Sep 2002 | - | -$3.39 M(+1.0%) |
| Jun 2002 | - | -$3.36 M(+1.0%) |
| Mar 2002 | - | -$3.32 M(+1.1%) |
| Dec 2001 | -$3.29 M(+11.1%) | -$3.29 M(+1.7%) |
| Sep 2001 | - | -$3.23 M(+1.5%) |
| Jun 2001 | - | -$3.18 M(+1.7%) |
| Mar 2001 | - | -$3.13 M(+5.8%) |
| Dec 2000 | -$2.96 M(+3.7%) | -$2.96 M(+2.2%) |
| Sep 2000 | - | -$2.89 M(-0.4%) |
| Jun 2000 | - | -$2.91 M(+0.4%) |
| Mar 2000 | - | -$2.89 M(+1.5%) |
| Dec 1999 | -$2.85 M(+53.8%) | -$2.85 M(+15.2%) |
| Sep 1999 | - | -$2.48 M(+9.3%) |
| Jun 1999 | - | -$2.26 M(+1.7%) |
| Mar 1999 | - | -$2.23 M |
| Dec 1998 | -$1.85 M(<-9900.0%) | - |
| Dec 1997 | $0.00(0.0%) | - |
| Dec 1996 | $0.00 | - |
FAQ
- What is Protalix BioTherapeutics annual retained earnings?
- What is the all time high annual retained earnings for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics annual retained earnings year-on-year change?
- What is Protalix BioTherapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics quarterly retained earnings year-on-year change?
What is Protalix BioTherapeutics annual retained earnings?
The current annual retained earnings of PLX is -$381.55 M
What is the all time high annual retained earnings for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high annual retained earnings is $0.00
What is Protalix BioTherapeutics annual retained earnings year-on-year change?
Over the past year, PLX annual retained earnings has changed by +$8.31 M (+2.13%)
What is Protalix BioTherapeutics quarterly retained earnings?
The current quarterly retained earnings of PLX is -$384.89 M
What is the all time high quarterly retained earnings for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high quarterly retained earnings is -$2.23 M
What is Protalix BioTherapeutics quarterly retained earnings year-on-year change?
Over the past year, PLX quarterly retained earnings has changed by -$9.38 M (-2.50%)